Sequential trial with B method of Potvin [Two-Stage / GS Designs]

posted by john john – Spain, 2015-10-01 19:44 (3560 d 05:48 ago) – Posting: # 15513
Views: 13,943

In a sequential clinical trial conducted like a B method of Potvin, we have Cmax and AUC both not bioequivalent. Cmax has a power <80% (71.5%), and AUC>80% (84.6%).
AUC 0-30min calculated by protocol is bioequivalent.
In the protocol it was not specified how to proceed in this situation.

Can we calculate a new n and pass to the second phase? Or we must stop the trial?

Thanks


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,682 registered users;
46 visitors (0 registered, 46 guests [including 11 identified bots]).
Forum time: 01:32 CEST (Europe/Vienna)

I think it is much more interesting to live with uncertainty
than to live with answers that might be wrong.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5